| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.3 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |